🎉 Gate xStocks Trading is Now Live! Spot, Futures, and Alpha Zone – All Open!
📝 Share your trading experience or screenshots on Gate Square to unlock $1,000 rewards!
🎁 5 top Square creators * $100 Futures Voucher
🎉 Share your post on X – Top 10 posts by views * extra $50
How to Participate:
1️⃣ Follow Gate_Square
2️⃣ Make an original post (at least 20 words) with #Gate xStocks Trading Share#
3️⃣ If you share on Twitter, submit post link here: https://www.gate.com/questionnaire/6854
Note: You may submit the form multiple times. More posts, higher chances to win!
📅 July 3, 7:00 – July 9,
The publicly listed company Prenetics will obtain more funds by selling its subsidiary ACT Genomics to explore Bitcoin reserve strategies.
PANews June 18 news, according to an official announcement, consumer health science company Prenetics (NASDAQ: PRE) has reached a final agreement to transfer its ownership of genomic medicine business ACT Genomics Holdings to Delta Electronics (TWSE: 2308). The total transaction value is up to $71.78 million, and Prenetics expects to receive approximately $46 million in cash. After the transaction is completed, the company’s cash reserves will increase to $86 million, with short-term assets reaching $117 million, while maintaining a zero-debt status. CEO Danny Yeung stated that the ample cash reserves will enable the company to explore innovative financial strategies such as digital asset and Bitcoin treasury management.